Q9973 HCPCS Level II code: Injection, epoetin beta, 1 microgram, (non-esrd use)
CMS terminated Q9973: its last date of service was Dec 31, 2014. It stays here for looking up older claims; newer services need a current code.
Official description
Q9973Injection, epoetin beta, 1 microgram, (non-esrd use)
Short description: Epoetin beta non esrd
HCPCS · United States
Notes for Q9973
As CMS prints them, with any note Q9973 takes from the headings above it.
Note
- CMS processing note 0195: PUB. 100-4, CH.4, SEC 240.
Medicare details
The indicators CMS publishes with Q9973 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Other carrier priced
- Type of service
- Other medical items or services
- BETOS category
- Other drugs
- Cross-reference
- See J0888
- Added
- Jul 1, 2014
- Terminated after
- Dec 31, 2014
Where Q9973 sits
- 1Q codesTemporary codes
- 2Terminated Q9973Injection, epoetin beta, 1 microgram, (non-esrd use)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code Q9973 still valid?
No. CMS terminated Q9973; its last date of service was Dec 31, 2014. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover Q9973?
CMS lists Q9973’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q9973
All Q codesQ9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per mlQ9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per mlQ9968Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mgQ9969Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study doseQ9970Injection, ferric carboxymaltose, 1mgQ9972Injection, epoetin beta, 1 microgram, (for esrd on dialysis)Q9974Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mgQ9975Injection, factor viii fc fusion protein (recombinant), per iuQ9976Injection, ferric pyrophosphate citrate solution, 0.1 mg of ironQ9977Compounded drug, not otherwise classifiedQ9978Netupitant 300 mg and palonosetron 0.5 mgQ9979Injection, alemtuzumab, 1 mg